R. T. MacFarland - Concepedia

Concepedia

Author

R. T. MacFarland

University of Washington

Also Known As

R MACFARLAND, R Macfarland, R T MacFarland, R. MacFarland, R. T. MacFarland, R. T. Macfarland, R. Trevor MacFarland, R.T. MacFarland, Ronald MacFarland, Ronald T MacFarland

20

Publications

1.3K

Citations

9

H-Index

23

Concepts

All Affiliations

University of Washington Johns Hopkins Medicine University of Arizona Seattle University Johns Hopkins University

RT

About

R. T. MacFarland is an author at University of Washington specializing in pharmacology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	583
2	Natural Sciences	1	1	221
3	Biochemistry	1	1	221
4	Cellular Physiology	1	1	221
5	Endocrinology	1	1	221

R. T. MacFarland

×

8

Publications

1.3K

Citations

8

H-Index

	Year	Citations
Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers Craig W. Hendrix, Charles Flexner, R. T. MacFarland, Antimicrobial Agents and Chemotherapy	2000	503
Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection Craig W. Hendrix, Ann C. Collier, Michael M. Lederman, JAIDS Journal of Acquired Immune Deficiency Syndromes Cxcr4 Receptor InhibitorMedicineAntiviral ActivityHuman RetrovirusImmunology	2004	362
High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. R. T. MacFarland, Bruce D. Zelus, Joseph A. Beavo Journal of Biological Chemistry High ConcentrationsCgs-pde PresentGlycobiologyAnp-induced DecreasesGlucocorticoid	1991	221
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34 hematopoietic progenitor cells by AMD3100 Nathan A. Lack, B. Green, David C. Dale, Clinical Pharmacology & Therapeutics	2005	73
CXCR4 antagonism as a therapeutic approach to prevent acute kidney injury Anna Żuk, Michael Gershenovich, Yulia V. Ivanova, American Journal of Physiology-Renal Physiology	2014	44
A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment R. T. MacFarland, Marjie Hard, Robert J. Scarborough, Biology of Blood and Marrow Transplantation	2009	26
Assessment of the Potential Pharmacokinetic Interaction Between Digoxin and Ethmozine R. T. MacFarland, Virginia Moeller, Henry J. Pieniaszek, The Journal of Clinical Pharmacology	1985	23
Extra-Hepatic Gsh–Dependent Metabolism Of 1,2-Dibromoethane (Dbe) And 1,2-Dibromo-3-Chloropropane (Dbcp) IN The Rat And Mouse R. T. MacFarland, A. Jay Gandolfi, I.G. Sipes Drug and Chemical Toxicology	1984	20

Page 1